Experts urge Pharmac to quickly fund the nirsevimab RSV vaccine to prevent thousands of infant hospitalisations, highlighting its potential to significantly reduce respiratory infections and improve access for vulnerable populations.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 2 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
dramatic drop in winter admissions
Rsv immunisation could prevent thousands of babies being hospitalisedrising child hospitalisations in winter
‘It’s awful’: Toddler sick eight times with respiratory illness as child hospitalisations surgeSpotted something wrong on this page? Report a correction.
